Ionis Pharmaceuticals (IONS)
(Delayed Data from NSDQ)
$43.03 USD
+0.05 (0.12%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $43.02 -0.01 (-0.02%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth C Momentum C VGM
Fundamental Charts
About Dividend Yield (TTM)
Ionis Pharmaceuticals, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Drugs industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
IONS 43.03 +0.05(0.12%)
Will IONS be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for IONS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for IONS
BioCryst Pharmaceuticals Before Q2 Earnings: How to Play the Stock
Ionis Beats on Q2 Earnings & Sales, Stock Up 5% on Raised '25 Outlook
IONS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Here's What Key Metrics Tell Us About Ionis Pharmaceuticals (IONS) Q2 Earnings
Ionis Pharmaceuticals (IONS) Q2 Earnings and Revenues Beat Estimates
Ionis Pharmaceuticals (IONS) Earnings Expected to Grow: Should You Buy?
Other News for IONS
Insider Sell: Brett Monia Sells Shares of Ionis Pharmaceuticals Inc (IONS)
Raymond James Raises Ionis Pharmaceuticals (IONS) Price Target to $64 | IONS Stock News
Deep Dive Into Ionis Pharmaceuticals Stock: Analyst Perspectives (6 Ratings)
Ionis Pharmaceuticals (IONS) Receives Analyst Upgrade and Price Target Increase | IONS Stock News
IONS Stock Update: HC Wainwright & Co. Raises Price Target to $65.00 | IONS Stock News